COVID-19 and cardiovascular disease: from bench to bedside

MK Chung, DA Zidar, MR Bristow, SJ Cameron… - Circulation …, 2021 - Am Heart Assoc
A pandemic of historic impact, coronavirus disease 2019 (COVID-19) has potential
consequences on the cardiovascular health of millions of people who survive infection …

[HTML][HTML] Myocardial T1 mapping: modalities and clinical applications

CL Jellis, DH Kwon - Cardiovascular diagnosis and therapy, 2014 - ncbi.nlm.nih.gov
Myocardial fibrosis appears to be linked to myocardial dysfunction in a multitude of non-
ischemic cardiomyopathies. Accurate non-invasive quantitation of this extra-cellular matrix …

Imaging-guided therapies for pericardial diseases

M Chetrit, B Xu, DH Kwon, J Ramchand… - Cardiovascular …, 2020 - jacc.org
Frequently, multimodality imaging is indispensable in the care of patients with pericardial
disease. With cardiac magnetic resonance imaging, pericardial inflammation can be …

Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic …

EL Kiehl, T Makki, R Kumar, D Gumber, DH Kwon… - Heart rhythm, 2016 - Elsevier
Background Right ventricular (RV) pacing may worsen left ventricular cardiomyopathy in
patients with reduced left ventricular ejection fraction (LVEF) and advanced atrioventricular …

Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and …

ZB Popović, DH Kwon, M Mishra, A Buakhamsri… - Journal of the American …, 2008 - Elsevier
The relationship among myocardial fibrosis, segmental strains, and hypertrophic
cardiomyopathy (HCM) in patients with preserved left ventricular ejection fraction is not …

Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular …

DH Kwon, NG Smedira, ER Rodriguez, C Tan… - Journal of the American …, 2009 - jacc.org
Objectives: In hypertrophic cardiomyopathy (HCM) patients undergoing surgical myectomy,
we sought to determine the association between pre-operative cardiac magnetic resonance …

Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac …

DH Kwon, CM Halley, TP Carrigan, V Zysek… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives: The objective of the study was to determine whether the extent of left ventricular
scar, measured with delayed hyperenhancement cardiac magnetic resonance (DHE-CMR) …

Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy

DH Kwon, RM Setser, M Thamilarasan, ZV Popovic… - Heart, 2008 - heart.bmj.com
Background: Abnormal papillary muscles (PM) are often found in hypertrophic
cardiomyopathy (HCM). Objective: To assess the relationship between morphological …

Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with …

AO Zurick, MA Bolen, DH Kwon, CD Tan… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives: The purpose of this study was to examine the prevalence and histopathologic
correlates of pericardial delayed hyperenhancement (DHE) seen with cardiac magnetic …

[HTML][HTML] Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing …

DH Kwon, NG Smedira, M Thamilarasan… - The Journal of thoracic …, 2010 - Elsevier
OBJECTIVE: In patients with hypertrophic cardiomyopathy with bifid hypermobile papillary
muscles and a dynamic left ventricular outflow tract gradient, we performed surgical papillary …